These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 12556576)

  • 1. Influence of the apolipoprotein E type 4 allele on cerebral glucose metabolism in Alzheimer's disease patients.
    Lee KU; Lee JS; Kim KW; Jhoo JH; Lee DY; Yoon JC; Lee JH; Lee DS; Lee MC; Woo JI
    J Neuropsychiatry Clin Neurosci; 2003; 15(1):78-83. PubMed ID: 12556576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age and ApoE genotype interaction in Alzheimer's disease: an FDG-PET study.
    Mosconi L; Sorbi S; Nacmias B; De Cristofaro MT; Fayyaz M; Bracco L; Herholz K; Pupi A
    Psychiatry Res; 2004 Feb; 130(2):141-51. PubMed ID: 15033184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease.
    Small GW; Mazziotta JC; Collins MT; Baxter LR; Phelps ME; Mandelkern MA; Kaplan A; La Rue A; Adamson CF; Chang L
    JAMA; 1995 Mar 22-29; 273(12):942-7. PubMed ID: 7884953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of association of apolipoprotein E epsilon4 allele dose with cerebral glucose metabolism in Alzheimer disease.
    Hirono N; Mori E; Yasuda M; Ishii K; Ikejiri Y; Imamura T; Shimomura T; Hashimoto M; Yamashita H; Sasaki M
    Alzheimer Dis Assoc Disord; 1998 Dec; 12(4):362-7. PubMed ID: 9876966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between apolipoprotein E e4 allele and arteriosclerosis, cerebral amyloid angiopathy, and cerebral white matter damage in Alzheimer's disease.
    Tian J; Shi J; Bailey K; Lendon CL; Pickering-Brown SM; Mann DM
    J Neurol Neurosurg Psychiatry; 2004 May; 75(5):696-9. PubMed ID: 15090562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain metabolic decreases related to the dose of the ApoE e4 allele in Alzheimer's disease.
    Mosconi L; Nacmias B; Sorbi S; De Cristofaro MT; Fayazz M; Tedde A; Bracco L; Herholz K; Pupi A
    J Neurol Neurosurg Psychiatry; 2004 Mar; 75(3):370-6. PubMed ID: 14966149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
    Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
    Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic interaction between ApoE genotype and onset age in Alzheimer's disease: implications for brain reserve.
    Mosconi L; Herholz K; Prohovnik I; Nacmias B; De Cristofaro MT; Fayyaz M; Bracco L; Sorbi S; Pupi A
    J Neurol Neurosurg Psychiatry; 2005 Jan; 76(1):15-23. PubMed ID: 15607989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inferior temporal lobe atrophy and APOE genotypes in Alzheimer's disease. X-ray computed tomography, magnetic resonance imaging and Xe-133 SPECT studies.
    Tanaka S; Kawamata J; Shimohama S; Akaki H; Akiguchi I; Kimura J; Ueda K
    Dement Geriatr Cogn Disord; 1998; 9(2):90-8. PubMed ID: 9524800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E polymorphism influences the cerebral metabolic pattern in Alzheimer's disease.
    Mielke R; Zerres K; Uhlhaas S; Kessler J; Heiss WD
    Neurosci Lett; 1998 Sep; 254(1):49-52. PubMed ID: 9780089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum zinc, copper, insulin and lipids in Alzheimer's disease epsilon 4 apolipoprotein E allele carriers.
    González C; Martín T; Cacho J; Breñas MT; Arroyo T; García-Berrocal B; Navajo JA; González-Buitrago JM
    Eur J Clin Invest; 1999 Jul; 29(7):637-42. PubMed ID: 10411671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypometabolism and altered cerebrospinal fluid markers in normal apolipoprotein E E4 carriers with subjective memory complaints.
    Mosconi L; De Santi S; Brys M; Tsui WH; Pirraglia E; Glodzik-Sobanska L; Rich KE; Switalski R; Mehta PD; Pratico D; Zinkowski R; Blennow K; de Leon MJ
    Biol Psychiatry; 2008 Mar; 63(6):609-18. PubMed ID: 17720148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral glucose metabolism in patients with AD and different APOE genotypes.
    Drzezga A; Riemenschneider M; Strassner B; Grimmer T; Peller M; Knoll A; Wagenpfeil S; Minoshima S; Schwaiger M; Kurz A
    Neurology; 2005 Jan; 64(1):102-7. PubMed ID: 15642911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease.
    Gomez-Isla T; West HL; Rebeck GW; Harr SD; Growdon JH; Locascio JJ; Perls TT; Lipsitz LA; Hyman BT
    Ann Neurol; 1996 Jan; 39(1):62-70. PubMed ID: 8572669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of positron emission tomography in diagnosing Alzheimer's disease.
    J Neurosci Nurs; 1996 Aug; 28(4):275. PubMed ID: 8880604
    [No Abstract]   [Full Text] [Related]  

  • 16. No difference in cerebral glucose metabolism in patients with Alzheimer disease and differing apolipoprotein E genotypes.
    Corder EH; Jelic V; Basun H; Lannfelt L; Valind S; Winblad B; Nordberg A
    Arch Neurol; 1997 Mar; 54(3):273-7. PubMed ID: 9074396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET.
    Mosconi L; Perani D; Sorbi S; Herholz K; Nacmias B; Holthoff V; Salmon E; Baron JC; De Cristofaro MT; Padovani A; Borroni B; Franceschi M; Bracco L; Pupi A
    Neurology; 2004 Dec; 63(12):2332-40. PubMed ID: 15623696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.
    Reiman EM; Caselli RJ; Yun LS; Chen K; Bandy D; Minoshima S; Thibodeau SN; Osborne D
    N Engl J Med; 1996 Mar; 334(12):752-8. PubMed ID: 8592548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein-E genotyping in Alzheimer's disease and frontotemporal dementia.
    Gustafson L; Abrahamson M; Grubb A; Nilsson K; Fex G
    Dement Geriatr Cogn Disord; 1997; 8(4):240-3. PubMed ID: 9213069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies.
    Higuchi M; Tashiro M; Arai H; Okamura N; Hara S; Higuchi S; Itoh M; Shin RW; Trojanowski JQ; Sasaki H
    Exp Neurol; 2000 Apr; 162(2):247-56. PubMed ID: 10739631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.